Marcin Frąckiewicz

Marcin Frąckiewicz is the CEO of TS2 Space and a longtime technology entrepreneur focused on telecommunications, satellite communications and digital innovation. A graduate of the Warsaw School of Economics (SGH), he writes about space technology, artificial intelligence and publicly traded technology companies. His analysis covers major market trends, emerging technologies and the businesses shaping the future of the global economy.

XRP price dips as Trump tariff uncertainty hits crypto — two Feb. 24 catalysts to watch

XRP price dips as Trump tariff uncertainty hits crypto — two Feb. 24 catalysts to watch

Karachi, February 24, 2026, 02:36 — Regular session XRP slipped Tuesday, losing 2.3% to $1.35 as traders reacted to U.S. tariff uncertainty rattling risk assets. The No. 4 digital coin by market value bounced between $1.35 and $1.42 in the last 24 hours, according to CoinMarketCap, while trading volume soared 164% to roughly $3.5 billion. Bitcoin dropped 4.4%. Ether shed 4.1%.
February 23, 2026
Shopify stock slides 7% after hours as tariff turmoil and AI fears batter tech

Shopify stock slides 7% after hours as tariff turmoil and AI fears batter tech

New York, February 23, 2026, 17:16 EST — Trading after the bell. Shopify Inc slid roughly 7% to $117.28 in Monday’s after-hours trade, deepening its decline and putting it almost $9 below where it finished on Friday. Shares bounced between $115.89 and $125.51, with volume at 12.6 million trades. The company’s market cap sits near $187 billion, putting its price-to-earnings ratio around 105.
February 23, 2026
Vanda Pharmaceuticals stock jumps 41% on Bysanti FDA approval filing as analysts weigh uptake risk

Vanda Pharmaceuticals stock jumps 41% on Bysanti FDA approval filing as analysts weigh uptake risk

New York, February 23, 2026, 16:52 — Trading after the bell. Vanda Pharmaceuticals Inc surged 41% on Monday, after a regulatory filing revealed the U.S. Food and Drug Administration gave the green light to its latest antipsychotic drug, Bysanti. Shares finished the session at $8.15, up $2.39. Trading volume spiked to about 47.6 million shares—roughly 26 times the usual daily number, market data showed.
February 23, 2026
Lithium Prices Face a China Reopen Test as Albemarle Stock Jumps Nearly 4%

Lithium Prices Face a China Reopen Test as Albemarle Stock Jumps Nearly 4%

New York, Feb 23, 2026, 15:13 EST — Regular session Albemarle Corp saw its stock climb 3.9% to $174.93 in Monday afternoon trading, pulling ahead of the broader market as investors watched lithium prices for signs of direction after China’s holiday slowdown. Shares in Chile’s SQM advanced 1.3%, while Lithium Americas edged up 0.4%, Google Finance data showed.
February 23, 2026
Oil prices slip, but Brent stays near $72 as Iran talks and Trump tariffs keep traders on edge

Oil prices slip, but Brent stays near $72 as Iran talks and Trump tariffs keep traders on edge

NEW YORK, February 23, 2026, 14:27 EST — Regular session Oil slipped Monday, though prices hovered close to a six-month peak as markets eyed upcoming U.S.-Iran nuclear negotiations and digested new tariff jitters. Brent crude gave up 37 cents to trade at $71.39 a barrel by 12:44 p.m. ET, down 0.52%. U.S. West Texas Intermediate dropped 27 cents, or 0.41%, landing at $66.21. “More open to talking about their nuclear program,” said Phil Flynn at Price Futures Group, citing recent signals out of Tehran.
February 23, 2026
1 199 200 201 202 203 244